News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Longer Tamoxifen Use Cuts Breast Cancer Deaths, University of Oxford Study


12/7/2012 7:13:11 AM

Breast cancer patients who double the length of time that they take a common medication can sharply reduce their risk of death, according to a new study that’s predicted to influence medical practice. The study involved an estrogen-blocking pill called tamoxifen, a standard hormonal therapy for the roughly two-thirds of breast cancer patients whose tumors are sensitive to estrogen. Taking tamoxifen for five years after diagnosis reduces breast cancer mortality by about one-third.

Read at News Release
Read at News Release
Read at Examiner
Read at News Release

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES